Lord, Abbett & Co. LLC Revolution Medicines, Inc. Transaction History
Lord, Abbett & Co. LLC
- $28.1 Billion
- Q1 2025
A detailed history of Lord, Abbett & Co. LLC transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Lord, Abbett & Co. LLC holds 367,630 shares of RVMD stock, worth $14.1 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
367,630
Previous 1,978,720
81.42%
Holding current value
$14.1 Million
Previous $86.5 Million
84.98%
% of portfolio
0.05%
Previous 0.27%
Shares
6 transactions
Others Institutions Holding RVMD
# of Institutions
307Shares Held
189MCall Options Held
186KPut Options Held
672K-
Vanguard Group Inc Valley Forge, PA16.6MShares$636 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA13.5MShares$518 Million2.75% of portfolio
-
Black Rock Inc. New York, NY13.4MShares$513 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA11.8MShares$451 Million0.08% of portfolio
-
Janus Henderson Group PLC London, X010.2MShares$390 Million0.21% of portfolio
About Revolution Medicines, Inc.
- Ticker RVMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,697,600
- Market Cap $3.36B
- Description
- Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...